GSK and Genmab Receive EU Authorization for Arzerra(tm) (ofatumumab) as First-Line Treatment for Chronic Lymphocytic Leukemia (CLL) in Combination with Chlorambucil or Bendamustine for Patients Ineligible for Fludarabine-based Therapy

World News: . []

COPENHAGEN Denmark July 3 2014 GLOBE NEWSWIRE -- LINK  CopenhagenGEN Todays decision by the LINK  Commission for the first-line use of Arzerra offers a new LINK  option for appropriate CLL patients and LINK  physicians fl exibili...

More news and information about Genmab A/S

Published By:

Globe Newswire: 14:38 GMT Thursday 3rd July 2014

Published: .

Search for other references to "genmab" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us